Clinical Trial
Catalunya Central Health region, Spain
COnV-ert study, convalescent plasma to stop COVID-19
Early administration of convalescent plasma in people over 50 years of age with mild to moderate COVID-19 disease may slow disease progression and decrease the severity of symptoms.

Institut Català de la Salut, Spain
E-speranza-COVID19 Project
This study aims to demonstrate efficacy of Montelukast for patients with persistent COVID-19 to help them improve their quality of life.

International
ANTICOV Study: COVID-19 in Africa
Collaborate with ANTICOV study to treat COVID-19 in Africa.



International
Solidarity Trial: COVID-19 Treatments
Solidarity is an international clinical trial to evaluate the effect of a number of drugs for the treatment of COVID-19.
France
COVIDAir: A New Technology To Detect COVID-19 Patients
This study aims to determine the validity of a new method to detect COVID-19 by characterising molecules in exhaled air.
Assistance Publique des Hopitaux de Paris, France
Convalescent plasma therapy and COVID-19
Convalescent plasma with anti-SARS-CoV-2 antibodies appears to be a very promising approach in the context of protracted COVID-19 symptoms in patients unable to mount a specific humoral response to SARS-CoV-2.
Hospital Infantil Universitario Niño Jesús, Spain
MESCEL-COVID19 Study
This clinical trial aims to explore the efficacy of allogeneic mesenchymal cells from umbilical cord tissue in patients with severe COVID-19 lung disease.
Cedars-Sinai Medical Center, Los Angeles
Progesterone for the Treatment of COVID-19
Can sex hormones help men survive COVID-19? This study assesses the safety and efficacy of progesterone for the treatment of COVID-19 in hospitalized men.
Hospital La Paz et al., Spain
PanCOVID19: Evaluating Pharmacological Treatments
Open, randomized, adaptive, phase III clinical trial study to evaluate the efficacy of various pharmacological alternatives in the treatment of severe infection in COVID-19 pediatric patients.
University of Rochester, New York
AstraZeneca Study of COVID-19 Vaccine Candidate AZD1222
Clinical trial designed to determine if the vaccine candidate, AZD1222, can prevent symptomatic COVID-19.
Georges-Pompidou European Hospital, France
STROMA-CoV2 Trial
The STROMA-CoV trial aims to treat patients with severe acute respiratory syndrome due to SARS-CoV-2 by intravenous administration of umbilical cord mesenchymal stromal cells.
Catalonia, Spain
Plants Against COVID-19
The study aims to identify plants based on traditional knowledge that can reduce or eliminate symptoms and the length of illness in non-hospitalised patients with COVID-19.